Skip to content
Open access

Plasma metabolic signatures of healthy dietary patterns and risk of metabolic dysfunction-associated steatotic liver disease and cirrhosis

Jul 2026 · Hepatology International · Vol 20, pp. 1058 - 1072 · 0 citations · 43 references
Medicine

TL;DR

Specific MSs linked to healthy dietary patterns are associated with reduced risk of liver disease, potentially underlying the diet's protective mechanism against MASLD and guiding future dietary guidelines in preventing progressive liver disease.

Abstract

The underlying mechanisms of the associations between dietary patterns and liver disease remain unclear. We aimed to identify metabolic signatures (MSs) reflecting adherence to ten healthy dietary patterns and to investigate their associations with metabolic dysfunction-associated steatotic liver disease (MASLD) and cirrhosis. This cohort study included 82,259 participants with detailed dietary and metabolomic data. MSs for each dietary pattern were derived using elastic-net regression. Cox proportional hazards regression, Mendelian randomization, and mediation analyses were employed to explore potential associations and mechanisms. MSs for ten healthy dietary patterns were derived from 31 to 116 metabolites, primarily comprising fatty acids, lipids, and lipoprotein subclasses. Across all patterns, MSs were consistently associated with a lower risk of MASLD, with hazard ratios (HRs) ranging from 0.59 to 0.76. Notably, MSs for MIND, HPDI, rE-DII, and HLCD were associated with reduced cirrhosis risk (HRs: 0.56 to 0.63). Mendelian randomization analysis supported a potential causal relationship between MSs of MED, MIND, HPDI, and EAT-Lancet diets and liver diseases. Mediation analysis revealed that specific MSs accounted for 20.1% to 29.4% of the association between dietary patterns and MASLD, and 25.7% to 27.4% of that with cirrhosis. Metabolites from fatty acid metabolism and lipoprotein subclasses were significantly linked to liver diseases, and substantial mediated effects were observed across these metabolic pathways. Specific MSs linked to healthy dietary patterns are associated with reduced risk of liver disease, potentially underlying the diet's protective mechanism against MASLD and guiding future dietary guidelines in preventing progressive liver disease.

Read PDF

Similar papers

Open access Aug 2026

Dietary Patterns, Metabolomics, and Incident Gastroesophageal Reflux Disease: A Prospective Cohort Study.

Prospective evidence linking overall diet quality to gastroesophageal reflux disease (GERD) is limited, and metabolic pathways remain unclear. In a cohort of 183,878 adults free of GERD at baseline, we examined nine dietary pattern scores derived from repeated 24-hour dietary recalls and assessed associations with inci...

Lei Zhang, Chunhui Ma, Yu Chen et al. · 0 citations
Review Aug 2026

The Mediating Role of Atherogenic Index of Plasma in the Association Between Dietary Inflammatory Index and Metabolic Syndrome: Evidence from NHANES and CHARLS

AIP is a key mediator linking proinflammatory diets to MetS, supporting the diet–inflammation–lipid axis and identifying targets for precision prevention.

Jiajun Sang, Ke-Xin Zhang, Cheng-Xia Kan et al. · 0 citations
Open access Sep 2026

Metabolomics highlights cardiovascular risk factor links to sphingolipid and one-carbon metabolism in asymptomatic adults

Serine depletion by increased demands of sphingolipid, and possibly transsulfuration pathway, metabolism is associated with elevations in cytotoxic deoxyceramides and reductions in glycine and methionine availability for one-carbon metabolism, a key marker of residual CVD risk.

Mengjiang Huang, D. Tacad, Tong Shen et al. · 0 citations
Open access Sep 2026

EAT-Lancet Diet-Associated Serum Metabolites Are Linked to Cardiovascular Disease and Mortality

Background: Higher adherence to the EAT-Lancet diet is associated with lower risk of cardiovascular disease (CVD) and all-cause mortality. Metabolomic profiling can identify biomarkers underlying these associations. Objective: To investigate metabolomic markers of the EAT-Lancet diet and risk of CVD and all-cause morta...

Wan-Jin Guan, Jia-Qi Yang, Jing-Sha Chen et al. · 0 citations
Open access Sep 2026

Dose–response relationship between tea consumption and mortality, cardiovascular, cerebrovascular, and renal outcomes in metabolic dysfunction-associated steatotic liver disease: a prospective cohort study

Background Tea is a widely consumed plant-derived beverage with potential metabolic and vascular effects, but its prognostic dose–response relationship in metabolic dysfunction-associated steatotic liver disease (MASLD) remains unclear. Methods We analyzed 360,548 UK Biobank participants, including 169,241 individuals...

Tom Ryu, Jaejun Lee, Ji Won Han et al. · 0 citations
Review Open access Aug 2026

Social Risk Profile, Planetary Health Diet, and Mortality Risk in Individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Population-Based Study.

Poor diet quality and social disadvantage were independently and jointly associated with increased mortality risk among US adults with MASLD, particularly those younger than 65 years.

Xin Li, Hui Fan, Qiuming Yao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.